宫氏脑针联合多巴丝肼治疗帕金森病临床观察

Clinical Observation on the Treatment of Parkinson’s Disease with Gongshi Cerebral Needle Combined with Dopamine Silk Hydrazine

目的:宫氏脑针联合多巴丝肼治疗帕金森病临床观察。方法:将符合标准的60例患者随机分为治疗组30例和对照组30例。2组均服多巴丝肼,治疗组加用宫氏脑针,2组观察周期均为2个月,治疗结束后评定疗效。结果:治疗后治疗组UPDRSI、II、III评分明显低于对照组,临床疗效明显高于对照组,均有统计学意义(P<0.01)。结果:宫氏脑针治疗帕金森病具有“简便、快捷、规范、效验”等特点,值得临床推广运用。

Objective: To study the clinical observation of the treatment of Parkinson's disease with uterine needle and Dopamine silk hydrazine. Methods: 60 cases were randomly divided into 30 cases of treatment group and 30 cases of control group. Both groups took Dopamine silk hydrazine, and the treatment group added a uterine brain needle. The observation period of the two groups was 2 months. After the treatment, the efficacy was assessed. Results: The score of UPDRS I, II and III was significantly lower than that of the control group, and the clinical effect was significantly higher than that of the control group (P<0.01). Conclusion: The treatment of Parkinson' s disease with Gong's brain needle has the characteristics of "simple, fast, standard and effective" and is worthy of clinical application.